Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ocular immunotherapy].

L Robbio Troyano

    Revista Alergia Mexico
    |March 1, 1989
    PubMed
    Summary

    Ocular immunotherapy effectively treated allergic conjunctivitis in 90.4% of patients. This study highlights the success of allergen immunotherapy for inhalant and fungal allergies affecting the eyes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Immunotherapy using the nasal route in bronchial asthma].

    Revista alergia Mexico·1989
    Same author

    [100 cases of chronic urticaria].

    Alergia·1983
    Same author

    [Chronic diarrhea and polyparasitosis].

    Revista cubana de medicina tropical·1982
    Same author

    [Value of intestinal parasitic diseases in allergic manifestations].

    Allergologia et immunopathologia·1979

    Area of Science:

    • Ophthalmology
    • Allergology
    • Immunology

    Background:

    • Allergic conjunctivitis, often triggered by inhalant allergens and fungi, can present with persistent symptoms.
    • Patients with refractory conjunctivitis were referred for specialized allergy evaluation.

    Purpose of the Study:

    • To evaluate the efficacy of ocular immunotherapy for allergic conjunctivitis.
    • To compare immunotherapy outcomes with a placebo control group.

    Main Methods:

    • Twenty-one patients with allergic conjunctivitis were enrolled.
    • A treatment group (14 patients) received ocular immunotherapy for two years.
    • A control group (7 patients) received placebo for one year, then switched to immunotherapy.
    • Allergen extracts were standardized by Proteic Nitrogen Units and administered as eye drops.

    Main Results:

    • Successful treatment outcomes were achieved in 90.4% of all patients.
    • The study demonstrated significant improvement in allergic conjunctivitis symptoms following immunotherapy.

    Conclusions:

    • Ocular immunotherapy is a highly effective treatment for allergic conjunctivitis caused by inhalant and fungal allergens.
    • Long-term immunotherapy can lead to sustained symptom relief and improved quality of life for affected individuals.

    Related Experiment Videos